Peter Lynch fit · Growth at a reasonable price (GARP)
Is Collegium Pharmaceutical, Inc. Common Stock (COLL) a Peter Lynch Stock?
Some GARP characteristics, but growth or valuation is stretched.
46/100
DMixed signals
4/6 criteria passed
Peter Lynch's Criteria, Applied to COLL
PEG ≤ 1.0
key—
EPS CAGR ≥ 15%
key20.4%
Revenue CAGR ≥ 10%
7.6%
Net margin > 0
7.7%
How COLL Scores on Other Strategies
Live Financial Snapshot
Market cap
$1.49B
P/E (TTM)
21.8x
ROIC (TTM)
9.78%
Gross margin
57.22%
Frequently Asked Questions
What is COLL's Peter Lynch fit score?
COLL scores 46/100 on our Peter Lynch fit engine — grade D. Some GARP characteristics, but growth or valuation is stretched.
Does Peter Lynch actually own COLL?
Our score is computed from financial fundamentals against Peter Lynch's published criteria. We don't claim that Peter Lynch personally owns or recommends COLL.
How often is this score updated?
COLL's Peter Lynch fit score is recomputed daily from the latest TTM financials.
Educational tool, not investment advice. Scores are computed from publicly-available financial data against published investing-strategy criteria. We do not claim that Peter Lynch personally owns or recommends COLL.